Xtl Biopharmaceuticals (XTLB) Current Assets (2009 - 2025)
Xtl Biopharmaceuticals' Current Assets came in at $166,000 for the quarter ended Dec 31, 2025, down 87.6% from $1.34 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Current Assets (2009 - 2025) Analysis & Trends
Going back to the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Current Assets data covers 43 quarters.
- Current Assets has declined in each of the last four years, with a five-year compound annual growth rate of -51.4% (years ended Dec 2020 to Dec 2025).
- Going back by year, Current Assets was $1.34 million in the year ended Dec 31, 2024 (-34.5%), $2.05 million in the year ended Dec 31, 2023 (-46.2%), $3.81 million in the year ended Dec 31, 2022 (-39.0%) and $6.24 million in the year ended Dec 31, 2021 (+1.9%).
- The figure for the quarter ended Dec 31, 2025 represents the lowest quarterly Current Assets in data going back to the quarter ended Mar 31, 2009.
- The fastest year-over-year change in Current Assets over five years came in the quarter ended Sep 30, 2021 (growth of 11.1%), and the weakest in the quarter ended Dec 31, 2025 (a decline of 87.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Xtl Biopharmaceuticals | 2.11 Bn | 2.11 Bn | - | 166,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Dec 31, 2022 | 3.81 Mn |
| Jun 30, 2022 | 5.38 Mn |
| Mar 31, 2022 | 6.24 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 6.47 Mn |
| Jun 30, 2021 | 6.57 Mn |
| Mar 31, 2021 | 6.93 Mn |
| Dec 31, 2020 | 6.12 Mn |
| Sep 30, 2020 | 5.83 Mn |
| Jun 30, 2020 | 6.41 Mn |
| Mar 31, 2020 | 6.89 Mn |
| Dec 31, 2019 | 6.83 Mn |
| Sep 30, 2019 | 7.91 Mn |
| Jun 30, 2019 | 9.17 Mn |
| Mar 31, 2019 | 12.05 Mn |
| Dec 31, 2018 | 8.20 Mn |
| Jun 30, 2018 | 6.06 Mn |
API Access
Xtl Biopharmaceuticals Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();